Chasing new hot topics! Goldman Sachs' first life science fund raised $650 million
六月清晨搅
发表于 2024-1-4 16:18:29
221
0
0
Goldman Sachs Asset Management announced on Wednesday that it has raised $650 million for West Street Life Sciences I, which will invest in startups related to the life sciences field.
Goldman Sachs Asset Management is one of the world's largest private capital management companies, investing in a comprehensive range of alternative investments, including private equity, growth equity, private credit, real estate, infrastructure, and sustainable development. West Street Life Sciences I was the first fund in the company's life science investment strategy, and the fund ultimately raised more than its target, becoming one of the largest first-ever growth private equity funds in life science history.
West Street Life Sciences I is managed by the Life Sciences Investment Group of Goldman Sachs Asset Management, which was established in 2021 and is led by Amit Sinha. The investment professionals of the life science investment team will utilize the extensive resources of the Goldman Sachs platform to seek differentiated investments and collaborate with the company to enhance value creation.
The team also has an advisory committee composed of scholars, clinical doctors, scientific experts, and entrepreneurs, with an average industry experience of over 24 years.
Strategic choices
Amit Sinha, Head of Life Sciences Investment at Goldman Sachs Asset Management, said, "We are in the golden age of life science innovation, and technological breakthroughs are creating new methods for diagnosing and treating diseases. We believe that the current environment provides attractive opportunities for investing in the next generation of leading life science companies."
The fund will focus on growth oriented private equity investments in the field of life sciences, particularly targeting early to medium-term treatment companies with multi asset portfolios in addition to life science equipment and diagnostic companies, with the goal of investing in the next generation of leading life science companies.
Marc Nachmann, Global Head of Asset and Wealth Management at Goldman Sachs, said, "Life sciences is one of the most exciting areas of private investment, and technological advancements are changing healthcare at an unprecedented pace."
Goldman Sachs stated that Life Sciences I has committed approximately $90 million to five companies, including cancer drug manufacturer Nested Therapeutics and precision medicine company MOMA Therapeutics. These investments cover precision medicine, immunotherapy, and artificial intelligence in the fields of oncology, neurology, and rare diseases.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Goldman Sachs raises Apple's target price from $265 to $275
- Non farm shock hits Wall Street! Goldman Sachs quickly raises economic recession forecast, global hedge fund bearish sentiment intensifies
- Xiaopeng Huitian raises $150 million in financing, flying cars are accelerating: Shenzhen's "flying" to Zhuhai takes only 20 minutes
- The sharp decline in the US stock market will lead to a slowdown in US GDP next year. Goldman Sachs research report explains the logic behind this
- What is the risk of a recession in the United States? Goldman Sachs' latest assessment: 20%! Whether there will be further downgrades in the future depends on non-agricultural sectors
- Global Technology Early Participation | Apple announces product launch event on September 10th; The first human commercial spacewalk is scheduled to start on Tuesday; AI programming assistant cursor raises $60 million in funding
- Goldman Sachs Lays Over a Thousand Employees, Wall Street Worries Over 'September Curse'
- Faraday Future announces $30 million funding commitment
- Faraday Future has received a $30 million funding commitment and meets Nasdaq's criteria for continued listing
- Are bulk commodities at the 'turning point'? Goldman Sachs' latest perspective is here!
-
每经AI快讯,据亿航智能官微消息,公司EH216-S无人驾驶电动垂直起降航空器(eVTOL)获得巴西国家民航局颁发的试验飞行许可证书,并计划在巴西进行测试和试飞。关于EH216-S无人驾驶eVTOL在巴西的认证,中国民航局 ...
- 潇湘才子
- 昨天 08:41
- 支持
- 反对
- 回复
- 收藏
-
今年7月,美国三大海外“债主”所持美国国债齐刷刷缩水,其中日本美债持仓已降至去年10月以来最低。 根据美国财政部当地时间9月18日公布的国际资本流动报告(TIC),2024年7月,美国前三大海外“债主”日本 ...
- 520hacker
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者俞立严)9月19日,蔚来全新品牌乐道的首款车型——乐道L60正式上市。新车定位家庭智能电动SUV,在采用BaaS电池租用服务后,L60的售价可低至14.99万元,电池租用月费最低为599元。乐道L6 ...
- anhao007
- 前天 11:03
- 支持
- 反对
- 回复
- 收藏
-
每经记者袁园 日前,国务院印发的《关于加强监管防范风险推动保险业高质量发展的若干意见》提出,以新能源汽车商业保险为重点,深化车险综合改革。 “车险综改”从2015年就已经开始逐步推进了,经过 ...
- moshulong
- 前天 21:50
- 支持
- 反对
- 回复
- 收藏